This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hows J, Beddow K, Gordon-Smith E et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation Blood 1986 67: 177 181
Klumpp TR . Immunohematologic complications of bone marrow transplantation Bone Marrow Transplant 1991 8: 159 170
Klumpp TR, Caliguiri MA, Rabinowe SN et al. Autoimmune pancytopenia following allogeneic bone marrow transplantation Bone Marrow Transplant 1990 6: 445 447
Horn B, Viele M, Mentzer W et al. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation Bone Marrow Transplant 1999 24: 1009 1013
Chen FE, Owen I, Savage D et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 491 495
Drobyski WR, Potluri J, Sauer D, Gottschall JL . Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 1093 1099
Wen L, Roberts SJ, Viney JL et al. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ (+) T cells Nature 1994 369: 654 658
Verlardi A, Speranza C, Terenzi A . Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny J Immunol 1988 141: 815 820
Grillo-Lopez AJ, White CA, Varns C et al. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma Semin Oncol 1999 26: 66 73
Lee EJ, Kueck B . Rituxan for the treatment of cold agglutinin disease (letter) Blood 1998 92: 3490 3491
Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ship, A., May, W. & Lucas, K. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation. Bone Marrow Transplant 29, 365–366 (2002). https://doi.org/10.1038/sj.bmt.1703371
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703371
This article is cited by
-
Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT
Bone Marrow Transplantation (2010)
-
Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT
Bone Marrow Transplantation (2008)